Dr Steven Burton

Guest Contributor
February 28, 2006

Dr Steven Burton has been appointed president and CEO of ProMetic Life BioSciences Ltd (PBL), after a reorganization of its parent firm, ProMetic Life Sciences Inc (PLS). Burton will be responsible for exploring financing opportunities in the UK, where the firm has an R&D laboratory and manufacturing facility. Most recently, he was executive VP of the Montreal-based firm's enabling technology business unit. Burton has more than 20 years of experience in the bioseparation industry and received a PhD from the Univ of Cambridge. Last November, PLS was restructured into four operating units. It develops, manufactures and markets technology applications used to purify biologics and the eliminate pathogens....

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.